Concordix Unveils a New Chewable-Emulsion Delivery at Vitafoods Asia to Improve Omega-3 and Vitamin Uptake
At Vitafoods Asia in Singapore, Norway-based formulation firm Concordix introduced an innovative chewable-emulsion delivery system positioned as a consumer-friendly alternative to bulky softgels and traditional tablets. The company’s patented approach turns oil-soluble ingredients into stabilized, flavor-masked chews that aim to speed absorption, preserve fragile actives and raise adherence-advantages that brands marketing omega-3s, vitamins and other specialty ingredients across Asia-Pacific can leverage to differentiate their portfolios.
What Concordix Presented: A Hybrid Between Confection and Pharmaceutical Delivery
Rather than simply offering another gummy or a bottled liquid, Concordix showcased a pre-emulsified, single-serving chew that blends confectionery sensory appeal with engineered performance. The format is intended to serve a wide consumer spectrum: parents seeking palatable omega-3s for children, middle-aged professionals wanting convenient cognitive-support supplements, and older adults who struggle with large capsules.
- Pre-emulsified lipid matrices designed to improve dissolution and uptake of lipophilic actives
- Texture and flavor engineering to boost acceptance in selective consumer segments
- Modular formulations to accommodate vitamins, omega-3s, minerals and niche bioactives
- Smaller unit doses to reduce pill burden versus high-dose softgels
Format Variants and Target Consumers
| Product Type | Leading Benefit | Primary Audience |
|---|---|---|
| Pre-emulsified chew | Faster availability and taste masking | Children, busy adults |
| Single-dose liquid shot | Immediate convenience and portability | Athletes, commuters |
| Gentle-digest chew | Lower gastric irritation | Seniors, sensitive stomachs |
The Science: How Emulsified Chews Can Enhance Absorption
Concordix’s technology converts oily actives into micro- or nano-scale droplets evenly dispersed within an edible matrix. A helpful comparison is emulsifying a vinaigrette so tiny oil droplets remain suspended in water-this increases exposed surface area and makes the oil more accessible. In the digestive tract, these pre-dispersed droplets provide enzymes quicker access, which can reduce variability in uptake versus taking intact oil in a softgel.
Using digital formulation tools, Concordix controls droplet diameter, emulsifier systems and texture so release kinetics, mouthfeel and shelf life can be tailored for specific markets. Technical benefits highlighted include:
- Micro-dispersion to increase surface area and enhance lipase interaction for improved absorption of lipophilic nutrients
- Regionally adapted flavor profiles to meet diverse Asia-Pacific taste preferences
- Matrix components that limit oxidation of sensitive lipids and stabilize vitamins
- Single-serving formats that reduce dosing inaccuracy and suit on-the-go lifestyles
The company presented in vitro gastrointestinal simulations indicating that oil-in-water chewable emulsions reduce inter-dose variation and raise the fraction of active available for uptake compared with comparable oil-filled capsules under identical test conditions. Concordix frames these findings as an early but promising basis for formulators considering a switch from large softgels to consumer-friendly chews.
Benefits Beyond Uptake: Palatability, Adherence and Formulation Versatility
Chewable emulsions address several long-standing hurdles for supplement developers:
- Masked off-flavors-marine oils and other strong-tasting actives can be effectively hidden, producing a more enjoyable sensory experience.
- Reduced swallowing challenges-smaller, chewable doses remove a common barrier for children and older adults who dislike or cannot swallow large capsules.
- Combination capability-the lipid-containing matrix can coexist with water-soluble nutrients, enabling multi-action products such as omega-3 plus vitamin D or prenatal blends.
- Marketing and labeling opportunities-novel dosage forms and clean-ingredient claims can provide effective shelf differentiation in crowded categories.
How Chewable Emulsions Compare With Other Dosage Forms
| Dosage Form | User Convenience | Oxidative Stability | Relative Absorption Potential |
|---|---|---|---|
| Softgel (oil-filled) | Moderate | Good | Baseline |
| Liquid syrup | Lower (taste/taking issues) | Moderate | Moderate |
| Chewable emulsion (Concordix) | High | High (with proper antioxidants) | Potentially higher |
Practical Use Cases: Where Chewable Emulsions Fit
During its Vitafoods sessions, Concordix outlined several real-world product concepts that illustrate the platform’s flexibility:
- Kid-focused omega-3 chews that neutralize fishy flavors while promoting consistent long-term intake.
- Workday cognitive-support chews combining lipophilic nootropics with B vitamins for professionals seeking convenient mental-edge formulations.
- Post-exercise single-serve shots blending fast-absorbing omega-3 emulsions with electrolytes and branched-chain amino acids for recovery.
- Prenatal chewable emulsions formulated to deliver DHA alongside folate and iron in a palatable daily dose for expectant mothers who struggle with large tablets.
These concepts align with broader consumer trends: shoppers increasingly value supplements that are easy to take, enjoyable to consume and supported by credible science. In APAC markets, where texture and flavor expectations vary widely, the capability to rapidly localize sensory profiles is particularly valuable.
Implications for Brands, Manufacturers and Regulators
Concordix’s chewable-emulsion platform has practical implications across the supply chain. Brand owners can use it to refresh established categories and introduce differentiated SKUs. Contract manufacturers may be able to adopt the technology with modest changes to existing production lines, accelerating time-to-market. At the same time, regulatory and quality teams must consider additional stability testing, oxidative protection strategies and, in many cases, targeted clinical or robust in vitro work to substantiate claims when replacing traditional dosage forms.
As regulators and consumers demand greater proof of label accuracy and performance, companies should plan for data packages-ranging from accelerated stability and in vitro digestion models to bioavailability trials-tailored to the claims they intend to make. A validated chewable-emulsion product that can demonstrate consistent functional advantages will likely command attention and licensing interest in competitive segments such as omega-3s and premium vitamin blends.
Market Context and Adoption Trends
Demand for palatable and convenient supplement formats has risen steadily over the last several years, driven by younger consumers and busy professionals. Industry observers have reported strong growth in functional gummies, chewables and single-serve formats throughout APAC, with product developers emphasizing taste, portability and scientifically supported delivery as key purchase drivers. For companies seeking to capitalize on these preferences, delivery innovations that combine sensory appeal with demonstrable bioavailability represent a strategic opportunity.
Conclusion: Delivery Innovation as a Competitive Lever
Concordix’s demonstration at Vitafoods Asia underscores a shifting view of dosage forms: they are increasingly a strategic tool for meeting consumer expectations, not merely a means of getting actives into the body. Chewable emulsions offer a pathway to better-tasting, easier-to-take formats that may also improve protection and uptake of lipophilic actives such as omega-3s and fat-soluble vitamins. While further independent testing and regulatory alignment will be essential to turn laboratory promise into broad market trust, the move toward more refined, consumer-first delivery systems is poised to accelerate as brands hunt for both efficacy and enjoyable user experiences.